Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04721418 · ClinicalTrials.gov registry record
Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study
A clinical trial of Cocaine Use Disorder and Healthy (Controls), sponsored by Yale University.
- Recruiting
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT04721418 is a study of Cocaine Use Disorder and Healthy (Controls) that is actively recruiting participants, run by Yale University. The registered enrollment target is 80 participants, below the 101-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (21% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04721418, a study of Cocaine Use Disorder and Healthy (Controls), is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.
Conditions Studied
Interventions
- RADIATION 11C-UCB-J
Study Locations (1)
Connecticut
- Connecticut Mental Health Center - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2021-07-20 |
| Est. Completion | 2026-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04721418
The ClinicalTrials.gov registry entry for NCT04721418 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 101-participant average among 26 other Cocaine Use Disorder trials with a reported enrollment target (21% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Cocaine Use Disorder appearing as the primary indexed condition, and to 1 intervention - of which 11C-UCB-J is the first listed.
NCT04721418 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT04721418 about?
NCT04721418 is a clinical study titled "Aberrant Synaptic Plasticity in Cocaine Use Disorder: A 11C-UCB-J PET Study". The purpose of this research study is to measure synaptic density in the brain comparing individuals with cocaine use disorder to healthy controls.
What is the current status of trial NCT04721418?
This trial is currently recruiting. The enrollment target is 80 participants. The study started on 2021-07-20. Estimated completion is 2026-06.
What conditions does trial NCT04721418 study?
This clinical trial studies the following conditions: Cocaine Use Disorder, Healthy (Controls).
What interventions are being tested in trial NCT04721418?
The interventions under investigation include: 11C-UCB-J (RADIATION).
Who is sponsoring clinical trial NCT04721418?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04721418 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cocaine Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
RECRUITING · Phase 2
-
Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
RECRUITING · Phase 2
-
Repurposing Semaglutide for the Treatment of Cocaine Use Disorder
RECRUITING · Phase 2
-
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
RECRUITING · NA
-
Cocaine Cue-reactivity Incubation Study
RECRUITING · NA
-
Cocaine and Pentoxifylline (BED IN 47)
RECRUITING · Early Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.